We are expecting the following by 31st of March:
1. FTO preclinical activity
2. George Clinical breast cancer trial review
3. AML programs
FTO preclinical activity should include the trial design for the melanoma and/or ccRCC preclinical FTO trials. Based on the announcement today, I am also expecting our first preclinical FTO results announcement describing the FTO expression in MCF-7 breast cancer cell lines. This will come under the FTO preclinical activity section.
All IMO
Ann: Compelling Preclinical Breast Cancer Results, page-131
-
- There are more pages in this discussion • 123 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.56 |
Change
-0.045(2.80%) |
Mkt cap ! $272.6M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.69 | $1.55 | $414.6K | 257.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 375 | $1.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.58 | 950 | 1 |
View Market Depth
| Last trade - 11.34am 30/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |